The Thalocan Clinical Outcomes Assessment platform (TRI-COA) is a powerful eCOA platform which has been designed for maximum flexibility and unprecedented speed of deployment. The cloud based, bring-your-own device application is purpose built to support decentralized clinical trials, with a patient profile creation flow designed to support improved skin of color data capture in disease presentation and assessment.  TRI-COA is built for dermatology but can be used to support any survey based CLINRO or ePRO.